Focal atrial tachycardia
Non-reentrant atrial tachycardia · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Focal atrial tachycardia arises from a single ectopic atrial focus producing a regular narrow-complex tachycardia with abnormal P-wave morphology. It may be incessant and cause a tachycardia-mediated cardiomyopathy if untreated.
Red flags
- Incessant tachycardia with falling LV function
- Haemodynamic instability
- Tachycardia in the context of digoxin toxicity
- Syncope or pre-syncope
- Failure to respond to multiple drugs
Assessment
Differential diagnosis
- AVNRT
- AVRT
- Atrial flutter
- Sinus tachycardia
- Multifocal atrial tachycardia
- Junctional tachycardia
Investigations
- 12-lead ECG (P-wave axis/morphology differs from sinus)
- Ambulatory monitor to capture onset/termination
- Echocardiogram for LV function
- Electrolytes including magnesium and potassium
- TFTs
- Electrophysiology study to localise the focus
Management
- Confirm a regular atrial tachycardia with abnormal P-wave morphology
- Identify warm-up/cool-down behaviour distinguishing it from re-entry
- Correct electrolyte disturbance and remove triggers (stimulants, digoxin toxicity)
- Assess LV function for tachycardia-mediated cardiomyopathy
- For acute control use vagal manoeuvres and adenosine (may terminate or reveal atrial activity)
- Rate-control with a beta-blocker or non-dihydropyridine calcium blocker
- Add an antiarrhythmic (flecainide or sotalol) if rate control inadequate
- Refer incessant or drug-refractory cases for catheter ablation
- Treat any reversible cause such as digoxin toxicity directly
- Re-image LV function after rhythm control to confirm recovery
- Counsel on recurrence and symptom monitoring
- Arrange electrophysiology follow-up
Drugs & doses
Metoprolol 25-100 mg PO BD (or bisoprolol 2.5-10 mg OD)
Verapamil SR 120-240 mg PO OD (if EF preserved)
Flecainide 50-150 mg PO BD (no structural heart disease)
Sotalol 80-160 mg PO BD
Adenosine 6 mg IV rapid push then 12 mg (diagnostic/therapeutic, acute)
Disposition
Cardiology/electrophysiology outpatient referral; ablation for refractory or incessant cases. Admit if haemodynamically unstable or cardiomyopathy.
Complications & pitfalls
- Tachycardia-mediated cardiomyopathy
- Heart failure
- Proarrhythmia from antiarrhythmics
- Recurrence after medical therapy
- Atrial remodelling
Exam pearls
- Unlike AVNRT/AVRT, adenosine may transiently block the AV node and unmask ongoing atrial activity rather than terminate it
- Catheter ablation has high success for a single focus and is preferred for incessant disease
- Suspect digoxin toxicity when atrial tachycardia occurs with AV block
- Tachycardia-mediated cardiomyopathy reverses once rhythm is controlled
- P-wave morphology helps localise the focus before ablation
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.